HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 289/1/G108    most recent 00012.2005v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Janssen, P. Articles by Lefebvre, R. A. Search for Related Content PubMed PubMed Citation Articles by Janssen, P. Articles by Lefebvre, R. A.

NEUROREGULATION AND MOTILITY

Characterization of 5-HT₇-receptor-mediated gastric relaxation in conscious dogs

¹Heymans Institute of Pharmacology, Ghent University, Ghent; and ²Johnson and Johnson Pharmaceutical Research and Development, Beerse, Belgium

Submitted 11 January 2005 ; accepted in final form 28 February 2005

We aimed to evaluate the gastric relaxant capacity of the 5-HT_1/7-receptor agonist 5-carboxamidotryptamine (5-CT) in conscious dogs and to clarify the mechanism of action by use of selective antagonists, vagotomy, and in vitro experiments. A barostat enabled us to monitor the intragastric volume in response to different treatments (intravenously administered) before and after supradiaphragmatic vagotomy [results presented as the maximum volume change after treatment (mean; n = 5–11)]. In vitro experiments were performed with isolated muscle strips cut from four different stomach regions of the vagotomized dogs [results were fitted to the operational model of agonism to determine the efficacy parameter (n = 5)]. 5-CT (0.5–10 µg/kg) caused a dose-dependent gastric relaxation (29–267 ml) that was completely blocked by the selective 5-HT₇-receptor antagonist SB-269970 (50 µg/kg). After vagotomy, the relaxation to 10 µg/kg 5-CT was significantly less pronounced (73 vs. 267 ml; P < 0.05) but still blocked by SB-269970, whereas the response to the nitric oxide donor nitroprusside was similar to that before vagotomy (178 vs. 218 ml). In vitro, 5-CT concentration dependently inhibited the PGF₂-contracted muscle strips before and after vagotomy. Although before and after vagotomy the response in every region was mediated by 5-HT₇ receptors (apparent affinity dissociation constant: SB-269970, 8.2–8.6 vs. 8.3–8.6, respectively), the response after vagotomy was less efficacious (log : 1.9 to 0.5 vs. 1.4 to –0.1). The results indicate that the 5-CT-induced proximal stomach relaxation in conscious dogs before and after vagotomy is mediated via 5-HT₇ receptors. The decreased efficacy of 5-CT in vitro after vagotomy is probably related to vagotomy-induced changes in receptor density or coupling efficiency and provides a possible explanation for the decreased in vivo response to 5-CT after vagotomy.

5-HT₇; efficacy distribution; vagotomy; barostat